![]() |
市場調查報告書
商品編碼
2128375
新生兒重症監護呼吸器市場規模、佔有率、成長、全球產業分析、區域洞察及2026年至2034年預測Neonatal Intensive Care Respiratory Devices Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034 |
||||||
全球新生兒重症監護呼吸器市場預計在2025年達到20.5億美元,2026年成長至21.7億美元,並在2034年達到30.8億美元,預測期內複合年成長率(CAGR)為4.47%。北美地區引領全球市場,預計到2025年將佔44.95%的市場佔有率,這主要得益於新生兒加護病房(NICU)入院人數眾多、呼吸窘迫症候群(RDS)發病率上升以及先進呼吸護理技術的快速普及。
新生兒呼吸照護設備對於治療早產兒和患有呼吸系統併發症(例如呼吸窘迫症候群、肺炎和其他呼吸系統疾病)的嚴重新生兒至關重要。根據世界衛生組織(WHO)統計,每年約有1500萬個嬰兒早產,約佔全球出生總數的11%。由於早產兒肺部發育往往不完善,早產兒數量的不斷增加促使世界各地新生兒加護病房(NICU)對先進呼吸支持系統的需求持續成長。
投資增加和策略合作推動市場成長。
新生兒加護病房呼吸器市場的主要趨勢之一是各大公司日益重視研發、產品創新和策略聯盟。這些公司正大力投資開發技術先進的人工呼吸器、持續性正壓呼吸器(CPAP)系統、氧氣控制器和呼吸監測解決方案,以改善新生兒的治療效果。
策略性收購也在加速市場擴張。各公司透過併購和產品研發不斷強化其新生兒護理產品系列,使醫護人員能夠獲得更有效率的呼吸支援技術。預計新生兒呼吸器和氧氣輸送系統的持續改進將在整個預測期內提升護理品質。
早產和呼吸窘迫症候群病例的增加正在推動需求成長。
市場成長的主要促進因素是早產兒呼吸窘迫症候群(RDS)發生率的上升。 RDS仍然是全球新生兒加護病房(NICU)收治和新生兒死亡的主要原因之一。早產兒通常需要即時獲得呼吸支持,包括持續性正壓呼吸器(CPAP)系統、人工呼吸器、氧氣鼻管、人工呼吸器、氧氣療法設備等。
人們對新生兒重症監護的認知不斷提高,醫院基礎設施也持續改善,這推動了先進呼吸治療設備的進一步普及。製造商也致力於開發智慧氧氣管理系統,以改善患者監測,同時減少氧氣療法相關的併發症。
自動化氧氣控制器、先進人工呼吸器和體外膜氧合(ECMO)系統等技術創新不斷改善新生兒的呼吸支持,從而支持市場的長期擴張。
醫療基礎設施不足限制了市場擴張。
儘管成長前景光明,但低收入和中等收入國家對先進新生兒呼吸照護設備的普及率仍然有限,這仍然是一項重大挑戰。許多開發中國家仍然面臨著設備齊全的新生兒加護病房 (NICU)、訓練有素的醫護人員以及採購先進呼吸設備所需資源的短缺問題。
此外,由於缺乏對新生兒呼吸照護指南和標準化治療方案的了解,常常導致診斷延遲和呼吸系統護理不足。這些因素持續限制著一些新興醫療保健市場的滲透率。
設備領域是市場的主要驅動力。
按產品類型分類,預計設備類產品將成為市場成長的主要驅動力,到2026年將佔85.43%的市場佔有率。人工呼吸器、持續性正壓呼吸器(CPAP)系統、體外膜氧合(ECMO)、氧氣控制器和其他呼吸支援設備的需求不斷成長,推動了該細分市場的成長。這些產品在早產兒呼吸窘迫症候群和其他肺部疾病的治療中發揮著至關重要的作用。
此外,由於新生兒護理中氧氣鼻管、呼吸管路、人工呼吸器、霧化器及相關呼吸配件的使用增加,配件和耗材領域預計也將強勁成長。
按最終用戶分類,預計到2026年,醫院領域將佔全球市場的68.51%,這主要得益於新生兒加護病房(NICU)入院人數的增加以及對新生兒重症監護基礎設施投資的擴大。此外,隨著越來越多的家長希望在家附近獲得先進的呼吸系統護理,對專科診所的需求也不斷成長。
北美繼續引領市場。
北美仍是最大的區域市場,預計2025年市場規模將達9.2億美元,2026年將達9.8億美元。該地區受益於新生兒重症監護室(NICU)的高入院率、先進的醫療基礎設施、有利的報銷機制以及持續的產品創新。在強力的法規核准和技術進步的推動下,光是美國市場預計到2026年就將達到9.1億美元。
預計到2025年,歐洲市場規模將達到5.7億美元,到2026年將達到6億美元,主要得益於對新生兒呼吸照護技術研發的大量投資。亞太地區預計2025年市場規模將達到3.7億美元,到2026年將達到3.9億美元。該地區預計將實現最快成長,這主要得益於醫療基礎設施的不斷完善、早產率的上升,以及中國、印度和日本等國家對設備齊全的新生兒重症監護室(NICU)需求的不斷成長。
預計到 2025 年,拉丁美洲市場規模將達到 1.1 億美元,並在 2026 年保持類似的成長動能。同時,在新生兒醫療保健設施改善的推動下,中東和非洲地區的市場持續穩定擴張。
詳細分解情況
The global neonatal intensive care respiratory devices market was valued at USD 2.05 billion in 2025 and is projected to grow from USD 2.17 billion in 2026 to USD 3.08 billion by 2034, registering a CAGR of 4.47% during the forecast period. North America dominated the global market with a 44.95% market share in 2025, supported by high neonatal intensive care unit (NICU) admissions, increasing prevalence of respiratory distress syndrome (RDS), and rapid adoption of advanced respiratory care technologies.
Neonatal respiratory care devices are essential for treating premature and critically ill newborns suffering from respiratory complications such as respiratory distress syndrome, pneumonia, and other breathing disorders. According to the World Health Organization (WHO), nearly 15 million babies are born prematurely every year, representing around 11% of all births worldwide. Since premature infants often have underdeveloped lungs, the growing number of preterm births continues to increase the demand for advanced respiratory support systems in NICUs across the globe.
Rising Investments and Strategic Collaborations Drive Market Growth
One of the key trends shaping the neonatal intensive care respiratory devices market is the growing focus on research, product innovation, and strategic partnerships among leading manufacturers. Companies are investing heavily in developing technologically advanced ventilators, CPAP systems, oxygen controllers, and respiratory monitoring solutions that improve neonatal outcomes.
Strategic acquisitions have also accelerated market expansion. Companies continue to strengthen their neonatal care portfolios through mergers and product development initiatives, allowing healthcare providers to access more efficient respiratory support technologies. Continuous improvements in neonatal ventilation systems and oxygen delivery devices are expected to enhance treatment quality throughout the forecast period.
Increasing Preterm Births and Respiratory Distress Syndrome Fuel Demand
The primary factor driving market growth is the rising incidence of respiratory distress syndrome among premature infants. RDS remains one of the leading causes of NICU admissions and neonatal mortality worldwide. Premature babies often require immediate respiratory assistance through CPAP systems, ventilators, nasal cannulas, resuscitators, and oxygen therapy devices.
Growing awareness regarding neonatal intensive care and continuous improvements in hospital infrastructure have further increased the adoption of advanced respiratory care equipment. Manufacturers are also focusing on introducing intelligent oxygen management systems that improve patient monitoring while reducing complications associated with oxygen therapy.
Technological innovations such as automated oxygen controllers, advanced ventilators, and extracorporeal membrane oxygenation (ECMO) systems continue to improve respiratory support for newborns, supporting long-term market expansion.
Limited Healthcare Infrastructure Restrains Market Expansion
Despite positive growth prospects, limited adoption of advanced neonatal respiratory care devices in low- and middle-income countries remains a major challenge. Many developing nations continue to face shortages of well-equipped NICUs, trained healthcare professionals, and financial resources required to procure sophisticated respiratory equipment.
In addition, limited awareness regarding neonatal respiratory care guidelines and standardized treatment protocols often results in delayed diagnosis and inadequate respiratory management. These factors continue to restrict market penetration across several emerging healthcare markets.
Devices Segment Leads the Market
Based on product type, the devices segment is expected to dominate the market with a 85.43% share in 2026. Increasing demand for mechanical ventilators, CPAP systems, extracorporeal membrane oxygenation (ECMO), oxygen controllers, and other respiratory support devices is driving segment growth. These products play a vital role in managing respiratory distress syndrome and other pulmonary disorders among premature infants.
The accessories & consumables segment is also expected to witness healthy growth due to increasing usage of nasal cannulas, breathing circuits, resuscitators, nebulizers, and related respiratory accessories during neonatal treatment.
By end-user, the hospitals segment is projected to account for 68.51% of the global market in 2026, supported by rising NICU admissions and growing investments in neonatal intensive care infrastructure. Specialty clinics are also experiencing increasing demand as parents seek advanced respiratory treatment closer to home.
North America Maintains Market Leadership
North America remained the largest regional market, generating USD 0.92 billion in 2025 and is projected to reach USD 0.98 billion in 2026. The region benefits from high NICU admission rates, advanced healthcare infrastructure, favorable reimbursement systems, and continuous product innovation. The U.S. market alone is expected to reach USD 0.91 billion in 2026, supported by strong regulatory approvals and technological advancements.
Europe accounted for USD 0.57 billion in 2025 and is projected to reach USD 0.60 billion in 2026, driven by significant investments in research and neonatal respiratory care technologies. Asia Pacific generated USD 0.37 billion in 2025 and is expected to reach USD 0.39 billion in 2026, recording the fastest growth due to expanding healthcare infrastructure, increasing preterm birth rates, and growing demand for fully equipped NICUs in countries such as China, India, and Japan.
Latin America generated USD 0.11 billion in 2025 and is projected to maintain similar growth in 2026, while the Middle East & Africa continues to witness gradual market expansion supported by improving neonatal healthcare facilities.
Competitive Landscape
The global neonatal intensive care respiratory devices market is moderately consolidated, with leading companies focusing on product innovation, acquisitions, and technological advancements to strengthen their market positions. Major players include Fisher & Paykel Healthcare Limited, Dragerwerk AG & Co. KGaA, GE Healthcare, Medtronic, Hamilton Medical, Vyaire Medical, GaleMed Corporation, SLE, and Airon Corporation.
Recent product developments continue to improve neonatal respiratory care. Drager received FDA approval for its Seattle Positive Airway Pressure (PAP) Plus System, while InnAccel introduced the portable neonatal CPAP device SAANS for infants with respiratory distress syndrome. Continuous investments in next-generation respiratory technologies are expected to further strengthen market competition.
Conclusion
The global neonatal intensive care respiratory devices market is expected to witness steady growth through 2034, driven by increasing preterm births, rising cases of neonatal respiratory distress syndrome, expanding NICU infrastructure, and continuous technological advancements in respiratory support systems. Although limited healthcare infrastructure in developing countries remains a challenge, ongoing investments in neonatal healthcare, product innovation, and hospital modernization are expected to create significant growth opportunities. As demand for advanced respiratory care continues to rise worldwide, neonatal respiratory devices will remain essential for improving survival rates and clinical outcomes among premature and critically ill newborns.
ATTRIB UTE DETAILS
Segmentation
By Product Type
By End User
By Geography